These studies show a widespread hypermethylation change in cancer, however since SETD2 alterations is linked with reduced H3K36me3, we predicted it would also lead to gene body hypomethylation through reduced H3K36me3-dependent DNMT3B recruitment. This evidence concerns the gene SETD2 and cancer.